COMMUNIQUÉS West-GlobeNewswire
-
Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress
12/06/2026 -
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
12/06/2026 -
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
12/06/2026 -
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12/06/2026 -
Le KFSH fait progresser les applications pratiques de l’IA pour transformer les soins de santé spécialisés
12/06/2026 -
Evaxion receives Prix Galien UK Award for Best digital health solution
12/06/2026 -
EAACI Calls for a "Vision Zero" Future Free from Allergy and Asthma Burden
12/06/2026 -
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
12/06/2026 -
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
12/06/2026 -
Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds
12/06/2026 -
Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis
11/06/2026 -
Hiding in Plain Sight: New Survey Exposes Awareness Gap Around the Second Most Common Type of Breast Cancer
11/06/2026 -
Precipio to Present at the Planet MicroCap Las Vegas
11/06/2026 -
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
11/06/2026 -
Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
11/06/2026 -
Crescent Biopharma Announces Grants of Inducement Awards
11/06/2026 -
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
11/06/2026 -
Treace to Present at the Sidoti Small Cap Conference
11/06/2026 -
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/06/2026
Pages